| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/29/2013 | WO2013124158A1 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| 08/29/2013 | WO2013124068A1 Combinations of albumin-based drug delivery systems |
| 08/29/2013 | WO2013124026A1 8 - substituted 2 -amino - [1,2,4] triazolo [1, 5 -a] pyrazines as syk tryrosine kinase inhibitors and gcn2 serin kinase inhibitors |
| 08/29/2013 | WO2013124025A1 Furopyridine derivatives |
| 08/29/2013 | WO2013123996A1 Novel sirna inhibitors of human icam-1 |
| 08/29/2013 | WO2013123618A1 Process for manufacture of extract containing zeaxanthin and/or its esters |
| 08/29/2013 | WO2013123588A1 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
| 08/29/2013 | WO2013098755A3 Anticancer fusion protein |
| 08/29/2013 | WO2011084991A3 Fluorinated hdac inhibitors and uses thereof |
| 08/29/2013 | US20130225546 Novel synthetic procedure and cancer treatment with cisplatin derivatives |
| 08/29/2013 | US20130225490 Antibodies That Inhibit TSLP Activity |
| 08/29/2013 | US20130225412 Silicon nanocarrier for delivery of drug, pesticides and herbicides , and for waste water treatment |
| 08/29/2013 | US20130224243 Use of herpes vectors for tumor therapy |
| 08/29/2013 | US20130224199 Viral chemokine-antigen fusion proteins |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | CA2807707A1 Compositions and methods for treating cancer |
| 08/28/2013 | EP2631291A2 Nucleic acid molecules inducing rna interference, and uses thereof |
| 08/28/2013 | EP2631233A1 Antagonist for mutated androgen receptor |
| 08/28/2013 | EP2631232A1 Halogen derivatives of benzo[b]furans useful as anti-neoplastic or anti-proliferative drugs |
| 08/28/2013 | EP2630971A1 Combinations of albumin-based drug delivery systems |
| 08/28/2013 | EP2630970A1 Cytotoxic immunoglobulin |
| 08/28/2013 | EP2630963A1 SPARC angiogenic domain and methods of use |
| 08/28/2013 | EP2630240A1 Compositions and methods for inhibiting expression of rrm2 genes |
| 08/28/2013 | EP2630238A1 Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | EP2630160A1 Erbb3 binding antibody |
| 08/28/2013 | EP2630149A1 Quinazolin-4 (3h) -one derivatives used as pi3 kinase inhibitors |
| 08/28/2013 | EP2630146A1 Crystaline (8s,9r)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1h-1,2,4-triazol-5-yl)-8,9-dihydro-2h-pyrido[4,3,2-de]phtalazin-3(7h)-one tosylate salt |
| 08/28/2013 | EP2630132A1 Pochoxime conjugates useful for the treatment of hsp90 related pathologies |
| 08/28/2013 | EP2630129A1 Quinoxaline derivates |
| 08/28/2013 | EP2630124A1 Tetrahydroquinoline derivatives used as ampk activators |
| 08/28/2013 | EP2629788A2 Use of human serum albumin to decrease antigenicity of therapeutic proteins |
| 08/28/2013 | EP2629776A2 Compounds, compositions and methods useful for cholesterol mobilisation |
| 08/28/2013 | CN1955280B Potency regeneration cell and culturing method thereof |
| 08/28/2013 | CN103270156A Wdhd1 peptides and vaccines including the same |
| 08/28/2013 | CN103270043A Process for the preparation of morpholinyl anthracycline derivatives |
| 08/28/2013 | CN103270037A Polymorphs and salts of 6-1h-indol-4-yl)-4-(5- { [4-(1-methylethyl)- 1-pi perazinyl] methyl} -1,3-oxazol-2-group)-1h-indazole as pi3k inhibitors for use in the treatment of e.g. respiratory disorders |
| 08/28/2013 | CN103270030A Hydrobromide salts of a pyrazolylaminoquinazoline |
| 08/28/2013 | CN103270026A Bi-heteroaryl compounds as vps34 inhibitors |
| 08/28/2013 | CN103270023A 4- { [ ( pyridin- 3 - Yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| 08/28/2013 | CN103269706A Anti-cancer extract and compounds |
| 08/28/2013 | CN103269701A Hsp90 inhibitors for treating non-mall cell lung cancers in wild-<wbr/>type egfr and/or kras patients |
| 08/28/2013 | CN103269700A Picropodophyllin polymorphs b or c for use in cancer therapy |
| 08/28/2013 | CN103267852A Application of fibroblast activation protein (FAP) alpha to preparation of pancreatic cancer prognosis kit |
| 08/28/2013 | CN103266121A Replicon DNA (deoxyribonucleic acid) vaccine vector, and construction method and application thereof |
| 08/28/2013 | CN103266111A Dual-target siRNA (small interfering ribonucleic acid) molecule and application thereof |
| 08/28/2013 | CN103265644A Preparation method of white muscardine silkworm anticancer-activity polysaccharide BBPW-2 |
| 08/28/2013 | CN103265643A Separating and purifying method for preparing white muscardine silkworm anticancer-activity polysaccharide BBPW-1 |
| 08/28/2013 | CN103265627A HPV16L1-g protein and coding gene and application thereof |
| 08/28/2013 | CN103265626A HPV16L1-f protein and coding gene and application thereof |
| 08/28/2013 | CN103265625A HPV16L1-h protein and coding gene and application thereof |
| 08/28/2013 | CN103265621A Tubulin depolymerizing agent polypeptide and application thereof |
| 08/28/2013 | CN103265606A Hederagenin amide derivative and preparation method and application thereof |
| 08/28/2013 | CN103265594A Garcinia acid amide derivative and preparation method thereof and purpose |
| 08/28/2013 | CN103265560A Gossypol/ cotton ketone derivative and preparation method thereof and application of derivative in anti-tumor medicament |
| 08/28/2013 | CN103265550A Alkaloid compound, preparation method thereof, application thereof in preparing paints resisting marine biofouling and anticancer drugs |
| 08/28/2013 | CN103265537A Antitumor compounds, preparation method and application thereof |
| 08/28/2013 | CN103265535A Antitumor compounds, preparation method and application thereof |
| 08/28/2013 | CN103265522A Lactone derivative derived from trichoderma citrinoviride and application thereof |
| 08/28/2013 | CN103265517A 3-substituted coumarin derivative and use thereof |
| 08/28/2013 | CN103265480A Quinolinedione derivative, and preparation method and use thereof |
| 08/28/2013 | CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors |
| 08/28/2013 | CN103265476A Azasugar quaternary ammonium salt compound and preparation method and application thereof |
| 08/28/2013 | CN103265452A Schiff base ligand and copper complex thereof and application |
| 08/28/2013 | CN103265442A Novel pleuromutilin derivatives, as well as preparation method and anti-tumour application thereof |
| 08/28/2013 | CN103265432A Drug for treating cancer pain |
| 08/28/2013 | CN103265431A Compound for treating cancer pain |
| 08/28/2013 | CN103263677A MicroRNA molecule and application thereof in preparation of cancer drug |
| 08/28/2013 | CN103263676A Method for reversing drug resistance of breast cancer by using miR-487a |
| 08/28/2013 | CN103263675A Poly (epsilon-caprolactone) supported anti-tumor prodrug and preparation method thereof |
| 08/28/2013 | CN103263673A Polysaccharide-gold-nanoparticle supermolecule assembled body as well as preparation method and application thereof |
| 08/28/2013 | CN103263672A Preparation method and application of nanometer particles of taxane drugs |
| 08/28/2013 | CN103263671A Preparation and application of anti-tumor activator nanostructure lipid carrier |
| 08/28/2013 | CN103263653A Tumor removing suppository |
| 08/28/2013 | CN103263587A Traditional Chinese medicine preparation for treating toxic and side effects of nasopharyngeal carcinoma after radiotherapy and preparation method thereof |
| 08/28/2013 | CN103263565A Traditional Chinese medicine preparation for treating leukemia and relieving side effects of chemotherapy |
| 08/28/2013 | CN103263541A Extract from traditional Chinese medicine and its preparation method |
| 08/28/2013 | CN103263526A Tumor, bone spurs, hyperplasia and blood stasis dispersing paste |
| 08/28/2013 | CN103263512A Traditional chinese medicine extract |
| 08/28/2013 | CN103263503A Traditional chinese medicine extract |
| 08/28/2013 | CN103263500A Traditional Chinese medicine extract and preparation method thereof |
| 08/28/2013 | CN103263499A Traditional chinese medicine extract |
| 08/28/2013 | CN103263493A Traditional Chinese medicine composition and preparation method thereof |
| 08/28/2013 | CN103263492A Traditional chinese medicine extract |
| 08/28/2013 | CN103263491A Traditional chinese medicine composition |
| 08/28/2013 | CN103263490A Extract from traditional Chinese medicine and its preparation method |
| 08/28/2013 | CN103263482A Extract from traditional Chinese medicine and its preparation method |
| 08/28/2013 | CN103263475A Traditional chinese medicine composition |
| 08/28/2013 | CN103263474A Traditional Chinese medicine composition and preparation method thereof |
| 08/28/2013 | CN103263473A Traditional Chinese medicine composition and preparation method thereof |
| 08/28/2013 | CN103263472A Traditional chinese medicine extract |
| 08/28/2013 | CN103263471A Traditional chinese medicine composition |
| 08/28/2013 | CN103263469A Traditional Chinese medicine composition and preparation method thereof |
| 08/28/2013 | CN103263464A Traditional Chinese medicine extract and preparation method thereof |
| 08/28/2013 | CN103263463A Traditional chinese medicine composition |
| 08/28/2013 | CN103263461A Application of silktree albizia bark water extract in preparation of anti-tumor medicaments |
| 08/28/2013 | CN103263457A Traditional Chinese medicine composition and preparation method thereof |
| 08/28/2013 | CN103263456A Traditional chinese medicine composition |
| 08/28/2013 | CN103263450A Traditional Chinese medicine compositio |
| 08/28/2013 | CN103263447A Dicranopteris pedata extract with prostatic cancer resistant effect and preparation method thereof |
| 08/28/2013 | CN103263446A Dicranopteris pedata extract with gastric cancer resistant effect and preparation method thereof |